PharmaTher Holdings Ltd.
PHRRF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $110 | $249 | $154 | $95 |
| G&A Expenses | $0 | $115 | $196 | $230 |
| SG&A Expenses | $134 | $278 | $196 | $230 |
| Sales & Mktg Exp. | $0 | $163 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $7 | $0 |
| Operating Expenses | $244 | $527 | $357 | $325 |
| Operating Income | -$244 | -$527 | -$357 | -$325 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$76 | $118 | -$12 | -$43 |
| Pre-Tax Income | -$320 | -$409 | -$369 | -$368 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$320 | -$409 | -$369 | -$368 |
| % Margin | – | – | – | – |
| EPS | -0.004 | -0.005 | -0.004 | -0.004 |
| % Growth | 23.9% | -9.5% | 0% | – |
| EPS Diluted | -0.004 | -0.007 | -0.004 | -0.004 |
| Weighted Avg Shares Out | 90,919 | 55,413 | 88,519 | 88,519 |
| Weighted Avg Shares Out Dil | 90,919 | 88,519 | 88,519 | 88,519 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $5 | $11 | $19 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$317 | -$527 | -$357 | -$346 |
| % Margin | – | – | – | – |